{"disease":{"id":"hcv-infection","name":"hcv infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06952036","title":"The Epidemic Status and Development Trend of Hepatitis C Virus Infection in Pregnant Women in Xi'an","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":200000,"lead_sponsor_name":"First Affiliated Hospital Xi'an Jiaotong University","has_results":false},{"nct_id":"NCT05992077","title":"Study of DAA Treatment for Children and Adolescents With Active HCV Infection in Cambodia","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":21000,"lead_sponsor_name":"ANRS, Emerging Infectious Diseases","has_results":false},{"nct_id":"NCT03145753","title":"Education vs Education Plus Intervention in HIV/HCV Diagnosis (DRIVE 03)","phase":"NA","overall_status":"COMPLETED","enrollment_count":7989,"lead_sponsor_name":"Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal","has_results":false},{"nct_id":"NCT04062253","title":"Addressing the Cascade of Care in Vulnerable Populations With Poor Access to Healthcare in Madrid","phase":"","overall_status":"COMPLETED","enrollment_count":2001,"lead_sponsor_name":"Hospital Universitario Infanta Leonor","has_results":false},{"nct_id":"NCT02219490","title":"A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":1596,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT04044586","title":"HIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST)","phase":"","overall_status":"UNKNOWN","enrollment_count":1098,"lead_sponsor_name":"ANRS, Emerging Infectious Diseases","has_results":false},{"nct_id":"NCT02021643","title":"Efficacy and Safety of Sofosbuvir Plus Ribavirin in Adults With Chronic HCV Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":687,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT02167945","title":"A Study to Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":615,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT01350648","title":"Long-Term Study of Liver Disease in People With Hepatitis B and/or Hepatitis C With or Without HIV Infection","phase":"","overall_status":"COMPLETED","enrollment_count":569,"lead_sponsor_name":"National Institutes of Health Clinical Center (CC)","has_results":false},{"nct_id":"NCT04008927","title":"A Community-based Intervention Among Active Drug Users in Montpellier","phase":"NA","overall_status":"COMPLETED","enrollment_count":554,"lead_sponsor_name":"ANRS, Emerging Infectious Diseases","has_results":false},{"nct_id":"NCT05395416","title":"Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C","phase":"PHASE2, PHASE3","overall_status":"COMPLETED","enrollment_count":514,"lead_sponsor_name":"Sunshine Lake Pharma Co., Ltd.","has_results":false},{"nct_id":"NCT05534633","title":"APPROACH 2.0: HIV, HCV and Syphilis Testing Through Pharmacies","phase":"NA","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":407,"lead_sponsor_name":"Memorial University of Newfoundland","has_results":false},{"nct_id":"NCT02021656","title":"Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination in Participants With Chronic Genotype 1 HCV Infection","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":384,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03487107","title":"Phase 3 Study of Yimitasvir Phosphate Capsules","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":362,"lead_sponsor_name":"Sunshine Lake Pharma Co., Ltd.","has_results":false},{"nct_id":"NCT07095192","title":"Scaling Up Point-of-Care Hepatitis C Testing and Treatment in Canada","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"McGill University","has_results":false},{"nct_id":"NCT03461250","title":"Chronic Hepatitis C in Chronic Hemodialysis Recipients - An Observational Study","phase":"","overall_status":"UNKNOWN","enrollment_count":293,"lead_sponsor_name":"Asociacion para el Estudio del Higado","has_results":false},{"nct_id":"NCT04134767","title":"Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)","phase":"NA","overall_status":"COMPLETED","enrollment_count":234,"lead_sponsor_name":"April M Young","has_results":true},{"nct_id":"NCT03214679","title":"Accessible HCV Care Intervention for People Who Inject Illicit Drugs (PWID)","phase":"NA","overall_status":"COMPLETED","enrollment_count":167,"lead_sponsor_name":"City University of New York, School of Public Health","has_results":true},{"nct_id":"NCT02247401","title":"Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"AbbVie","has_results":true},{"nct_id":"NCT02707601","title":"Efficacy, Safety, and Tolerability of Ledipasvir/Sofosbuvir (LDV/SOF) Treatment for HIV/HCV Co-infected Participants Who Switch to Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide (E/C/F/TAF) or Emtricitabine/Rilpivirine/Tenofovir Alafenamide (F/R/TAF) Prior to LDV/SOF HCV Treatment","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":150,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03458481","title":"Phase 2 Study of Yimitasvir Phosphate Capsules","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":129,"lead_sponsor_name":"Sunshine Lake Pharma Co., Ltd.","has_results":false},{"nct_id":"NCT03111108","title":"Efficacy and Safety of Elbasvir (MK-8742) + Grazoprevir (MK-5172) in Treatment-Naïve/Treatment-Experienced (TN/TE) French Participants With Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection (MK-5172-096)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":117,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03499639","title":"Ombitasvir/ Paritaprevir / Ritonavir Plus Ribavirin in Management HCV and End-stage Kidney Disease","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT03508115","title":"Changes in Cognition in HCV Patients After Virus Eradication With Direct Antiviral Agents","phase":"","overall_status":"COMPLETED","enrollment_count":80,"lead_sponsor_name":"Corporacion Parc Tauli","has_results":false},{"nct_id":"NCT04405011","title":"NUC in Preventing HBV Reactivation in HCV/HBV Co-infected Patients Receiving DAA for CHC","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT03379506","title":"Elbasvir (EBR)/Grazoprevir (GZR) in Pediatric Participants With Chronic Hepatitis C Infection (MK-5172-079)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":57,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT03540212","title":"Clinical Pharmacokinetics of Daclatasvir/Sofosbuvir in Adolescents With Hepatitis C Virus","phase":"PHASE2, PHASE3","overall_status":"UNKNOWN","enrollment_count":50,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT01900015","title":"Changes in Liver Steatosis After Switching to Raltegravir in HIV/HCV Coinfection","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":45,"lead_sponsor_name":"Juan Macías","has_results":false},{"nct_id":"NCT03549832","title":"Comparative Study of Two Regiemns in Management of Sofosbuvir/Daclatasvir Failure","phase":"NA","overall_status":"COMPLETED","enrollment_count":40,"lead_sponsor_name":"Assiut University","has_results":false},{"nct_id":"NCT01958281","title":"Sofosbuvir Plus Ribavirin, or Ledipasvir/Sofosbuvir in Adults With HCV Infection and Renal Insufficiency","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":38,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT02397707","title":"Pharmacokinetics of Voxilaprevir in Adults With Normal Hepatic Function and Moderate or Severe Hepatic Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":33,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT03674125","title":"Evaluation of Safety, Tolerability, and Immunogenicity Study of GLS-6150 in Healthy Volunteers and in Persons Previously Treated for Hepatitis C Virus Infection","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":32,"lead_sponsor_name":"GeneOne Life Science, Inc.","has_results":false},{"nct_id":"NCT00401947","title":"A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of ACH-0137171 in Participants With Chronic Hepatitis C Infection","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":30,"lead_sponsor_name":"Alexion Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04159246","title":"Role OF OCT-A TO Detect Possible Retinal Vascular Complications of Sofosbuvir in Patients With Hepatitis C","phase":"","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Mohamed Saad","has_results":false},{"nct_id":"NCT03588923","title":"Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of SH229 in Patients With HCV Infection","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Nanjing Sanhome Pharmaceutical, Co., Ltd.","has_results":false},{"nct_id":"NCT03549312","title":"Switch to Genvoya Followed by HCV Therapy With Epclusa Followed by Simplification of HIV Therapy With Biktarvy in Patients With HIV-HCV Co-Infected Subjects on Opioid Substitution Therapy","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":25,"lead_sponsor_name":"Saskatchewan Health Authority - Regina Area","has_results":false},{"nct_id":"NCT02783976","title":"Sovaldi-based Regimens in Patients in Mexico With Chronic Hepatitis C Virus Infection in Clinical Practice","phase":"","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Gilead Sciences","has_results":false},{"nct_id":"NCT02402452","title":"Pharmacokinetics of Voxilaprevir in Adults With Normal Renal Function and Severe Renal Impairment","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT01707472","title":"Study of Simtuzumab in HIV and/or Hepatitis C- Infected Adults With Liver Fibrosis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT02533427","title":"Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"Gilead Sciences","has_results":true},{"nct_id":"NCT04019717","title":"Study of AT-527 in Combination With Daclatasvir in Subjects With Hepatitis C Virus (HCV) Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Atea Pharmaceuticals, Inc.","has_results":false},{"nct_id":"NCT04513899","title":"Development of a Community-based HCV Treatment Completion Intervention Among HCV Positive Homeless Adults","phase":"NA","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"University of California, Irvine","has_results":true},{"nct_id":"NCT03050905","title":"Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":7,"lead_sponsor_name":"HaEmek Medical Center, Israel","has_results":false},{"nct_id":"NCT04235049","title":"Elimination of HCV Through Linkage and In Prison Treatment of Incarcerated Populations (ECLIPSE)","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Maryland, Baltimore","has_results":false},{"nct_id":"NCT03794258","title":"Triple or Quadruple Combination DAAs Treatment for Subjects With HCV GT 1b Infection","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Humanity & Health Medical Group Limited","has_results":false}],"total":45},"guidelines":[],"source":"Drug Landscape verified database"}